The term designating a substance being an active ingredient of a drug may be a generic name, a nonproprietary name, a registered trade name, a fantasy name, or other. This causes difficulties in the transmission of requests and reports on properties for such substances in biological fluids to and from the clinical laboratories, and in the collating of this information from different sources.
The document comprises a list of properties of drugs in biological
fluids for use in electronic transmission systems. Systematic names
are presented together with a code value for each.